NEW YORK, May 10, 2022 /PRNewswire/ The global pharmacovigilance market is expected to reach $15,259.8 million by 2030 from $6,724.2 million in 2021, growing at a CAGR of 9.5% during 2021-2030
- Pharmacovigilance market participants are expanding their services to include preclinical research, clinical trial stages I, II, III, and IV, which is projected to help the pharmacovigilance
/PRNewswire/ The global pharmacovigilance market was worth around US$ 6.1 Bn in 2020 and the global market is estimated to attain valuation of US$ 11.5 Bn.
/PRNewswire/ The global pharmacovigilance market was worth around US$ 6.1 Bn in 2020 and the global market is estimated to attain valuation of US$ 11.5 Bn.